Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06063200 · ClinicalTrials.gov registry record · Early Phase 1
Methylphenidate and Response to Alcohol Cues Pilot Study
A Early Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 31
- Enrollment target
NCT06063200 is a Early Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 31 participants.
The verdict
NCT06063200, a Early Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 31 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether changes in attention levels related to taking a single dose of a medication called methylphenidate, also known as Ritalin, affects responses to alcohol cues. The study will observe the effects of methylphenidate or a placebo on attentional bias and craving responses to alcohol cues through fMRI, EEG, and behavioral testing. Participants will be involved in one remote and two in-person sessions.
Interventions
- DRUG Methylphenidate Pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2024-03-20 |
| Est. Completion | 2025-07-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06063200
The ClinicalTrials.gov registry entry for NCT06063200 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Methylphenidate Pill is the first listed.
NCT06063200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06063200 about?
NCT06063200 is a clinical study titled "Methylphenidate and Response to Alcohol Cues Pilot Study". The purpose of this study is to determine whether changes in attention levels related to taking a single dose of a medication called methylphenidate, also known as Ritalin, affects responses to alcohol cues. The study will observe the effects of methylphenidate or a placebo on attentional bias and c...
What is the current status of trial NCT06063200?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 31 participants. The study started on 2024-03-20. Estimated completion is 2025-07-01.
What interventions are being tested in trial NCT06063200?
The interventions under investigation include: Methylphenidate Pill (DRUG).
Who is sponsoring clinical trial NCT06063200?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.